Am J Perinatol 2016; 33(07): 703-707
DOI: 10.1055/s-0036-1571321
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Preeclampsia and Future Risk for Maternal Ophthalmic Complications

Ofer Beharier
1   Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Ehud Davidson
2   Faculty of Health Sciences, Soroka University Medical Center, Clalit Health Services (Southern District), Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Ruslan Sergienko
3   Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Irit Szaingurten-Solodkin
4   Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Roy Kessous
1   Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Ron Charach
1   Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Nadav J. Belfair
5   Department of Ophthalmology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Eyal Sheiner
1   Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel
› Author Affiliations
Further Information

Publication History

06 August 2015

03 December 2015

Publication Date:
12 February 2016 (online)

Abstract

Objective To investigate whether patients with a history of preeclampsia have an increased risk of long-term ophthalmic complications.

Study Design A population-based study comparing the incidence of long-term maternal ophthalmic complications in a cohort of women with and without a history of preeclampsia.

Results During the study period, a total of 103,183 deliveries met the inclusion criteria; 8.1% (n = 8,324) occurred in patients with a diagnosis of preeclampsia during at least one of their pregnancies. Patients with preeclampsia had a significantly higher incidence of long-term ophthalmic morbidity such as diabetic retinopathy and retinal detachment. In addition, a positive linear correlation was found between the severity of preeclampsia and the prevalence of future ophthalmic morbidities (0.3 vs. 0.5 vs. 2.2%, respectively). Kaplan–Meier survival curve indicated that women with preeclampsia had higher rates of total ophthalmic morbidity (0.2 vs. 0.4%, for no preeclampsia and with preeclampsia, respectively; odds ratio = 2.06, 95% confidence interval: 1.42–2.99; p < 0.001). In a Cox proportional hazards model, adjusted for confounders, a history of preeclampsia remained independently associated with ophthalmic complications.

Conclusion Preeclampsia is an independent risk factor for long-term maternal ophthalmic morbidity, specifically diabetic retinopathy and retinal detachment. This risk is more substantial depending on the severity of the disease.

Note

The authors are responsible for study design; collection, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication.


This study was presented at the 35th Annual Meeting of the Society for Maternal-Fetal Medicine, February 2–7, 2015, San Diego, CA; Accepted for poster presentation.


Supplementary Material

 
  • References

  • 1 Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005; 1 (2) 98-114 , quiz 120
  • 2 Jaffe G, Schatz H. Ocular manifestations of preeclampsia. Am J Ophthalmol 1987; 103 (3, Pt 1): 309-315
  • 3 Abu Samra K. The eye and visual system in the preeclampsia/eclampsia syndrome: what to expect?. Saudi J Ophthalmol 2013; 27 (1) 51-53
  • 4 Schultz KL, Birnbaum AD, Goldstein DA. Ocular disease in pregnancy. Curr Opin Ophthalmol 2005; 16 (5) 308-314
  • 5 Vigil-De Gracia P, Ortega-Paz L. Retinal detachment in association with pre-eclampsia, eclampsia, and HELLP syndrome. Int J Gynaecol Obstet 2011; 114 (3) 223-225
  • 6 Errera MH, Kohly RP, da Cruz L. Pregnancy-associated retinal diseases and their management. Surv Ophthalmol 2013; 58 (2) 127-142
  • 7 Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010; 28 (7) 1349-1355
  • 8 Garovic VD, Hayman SR. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007; 3 (11) 613-622
  • 9 Hermes W, Ket JC, van Pampus MG , et al. Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis. Obstet Gynecol Surv 2012; 67 (12) 793-809
  • 10 Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther 2007; 5 (2) 283-294
  • 11 Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Sheiner E. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 2015; 101 (6) 442-446
  • 12 Shalom G, Shoham-Vardi I, Sergienko R, Wiznitzer A, Sherf M, Sheiner E. Is preeclampsia a significant risk factor for long-term hospitalizations and morbidity?. J Matern Fetal Neonatal Med 2013; 26 (1) 13-15
  • 13 Gordin D, Kaaja R, Forsblom C, Hiilesmaa V, Teramo K, Groop PH. Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life. Acta Diabetol 2013; 50 (5) 781-787
  • 14 Lupton SJ, Chiu CL, Hodgson LA , et al. Changes in retinal microvascular caliber precede the clinical onset of preeclampsia. Hypertension 2013; 62 (5) 899-904
  • 15 American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122 (5) 1122-1131
  • 16 Statistics TCBo. Israel in Figures 2013. Available at: http://www.cbs.gov.il/www/publications/isr_in_n13e.pdf 2013:1–32. Accessed November 15, 2015
  • 17 Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010; 5: 173-192
  • 18 Vadlapatla RK, Vadlapudi AD, Mitra AK. Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases. Curr Drug Targets 2013; 14 (8) 919-935
  • 19 Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 2012; 87 (6) 134
  • 20 Launay-Vacher V, Deray G. Hypertension and proteinuria: a class-effect of antiangiogenic therapies. Anticancer Drugs 2009; 20 (1) 81-82
  • 21 Schneider S, Freerksen N, Maul H, Roehrig S, Fischer B, Hoeft B. Risk groups and maternal-neonatal complications of preeclampsia—current results from the national German Perinatal Quality Registry. J Perinat Med 2011; 39 (3) 257-265
  • 22 Schneider S, Freerksen N, Röhrig S, Hoeft B, Maul H. Gestational diabetes and preeclampsia—similar risk factor profiles?. Early Hum Dev 2012; 88 (3) 179-184
  • 23 Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25 (4) 391-403
  • 24 Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007; 34 (2) 173-199 , vii
  • 25 Chu SY, Callaghan WM, Kim SY , et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007; 30 (8) 2070-2076
  • 26 Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 2004; 6 (Suppl. 02) S125-S140